Skip to main content
Log in

Acemannan

CARN 1000, CARN 750, Polymannoacetate, Aliminase®, Alovex®, Carrisyn®

  • Adis R&D Profile
  • Section 2: Inflammatory Bowel Disorders
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Fogleman RW, Chapdelaine JM, Carpenter RH, et al. Toxicologic evaluation of injectable acemannan in the mouse, rat and dog. Vet Hum Toxicol 1992 Jun; 34: 201–5

    PubMed  CAS  Google Scholar 

  2. Montaner JSG, Gill J, Singer J, et al. Double-blind placebo-controlled pilot trial of acemannan in advanced human immunodeficiency virus disease. J Acquir Immune Defic Syndr Hum Retrovirol 1996 Jun 1; 12: 153–7

    Article  PubMed  CAS  Google Scholar 

  3. Robinson M, Reich C, Lashner B, et al. Evaluation of oral acemannan in active ulcerative colitis. Am J Gastroenterol 1994 Sep; 89: 1697

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Acemannan. Drugs R&D 1, 251–252 (1999). https://doi.org/10.2165/00126839-199901030-00013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199901030-00013

Keywords

Navigation